Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
GlaxoSmithKline Urges MDL Judge To Revisit Pre-Emption in Zofran Lawsuits Over Pregnancy Risks June 7, 2019 Irvin Jackson Add Your Comments Following a recent ruling by the U.S. Supreme Court, GlaxoSmithKline is asking the federal judge presiding over all federal Zofran birth defect lawsuits to reconsider a prior motion to dismiss the litigation, indicating that the determination about whether the FDA would have allowed the drug maker to update pregnancy warnings would have been permitted. GlaxoSmithKline currently faces more than 400 product liability lawsuits brought by families nationwide, each involving allegations that consumers and the medical community were not adequately warned about the potential Zofran pregnancy risks, including claims that use of the anti-nausea drug caused children to develop severe birth defects, such as cleft palates, cleft lips, atrial septal defects, ventricular septal defects and other congenital malformations. Zofran has been commonly prescribed “off-label” for symptoms of morning sickness, and plaintiffs claim GlaxoSmithKline failed to provide sufficient pregnancy warnings. However, the drug maker has previously sought to dismiss the cases, arguing that the claims are pre-empted by federal law, since the FDA would not have allowed a pregnancy warning. Learn More About Zofran Lawsuits Use of Zofran in Pregnancy May Increase the Risk that Children Suffer Cleft Palate, Cleft Lip, Heart Defects or Other Malformations. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Zofran Lawsuits Use of Zofran in Pregnancy May Increase the Risk that Children Suffer Cleft Palate, Cleft Lip, Heart Defects or Other Malformations. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given the similar questions of fact and law presented in the litigation, cases filed in U.S. District Courts nationwide have been centralized for coordinated pretrial proceedings before U.S. District Judge Dennis Saylor in the District of Massachusetts, to reduce duplicative discovery, avoid conflicting pretrial rulings from different courts, and to serve the convenience of the parties, witnesses and the judicial system. In February, Judge Saylor denied a motion for summary judgment, clearing the way for the first cases to go before a jury as part of a “bellwether” trial in September 2019, which was designed to help gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout the litigation. However, last month the U.S. Supreme Court issued an opinion on a case involving the osteoporosis drug Fosamax, which clarified the standard that drug makers must establish to maintain a pre-emption defense. In that case, Merck & Co. claimed it was exempt from charges of failure to warn, because the FDA allegedly rejected its efforts to add new label warnings to Fosamax. In the decision, the Supreme Court justices unanimously determined that to maintain a pre-emption defense a judge, not a jury, must determine whether there is clear evidence a drug maker fully informed the FDA about the justifications for adding such warnings, and that such warnings were rejected. On May 20, Judge Saylor asked both parties in Zofran litigation to submit memorandum on how the court should proceed in light of the recent ruling, as the prior motion for summary judgment filed by GlaxoSmithKline argued that the FDA previously rejected warnings that plaintiffs now argue should have been provided. However, the Court previously determined that it was a jury question whether the drug maker failed to provide complete information, and whether that was material in the prior regulatory decision. In a memorandum (PDF) filed on June 3, GlaxoSmithKline renews the request for summary judgment in light of the standard recently articulated by the U.S. Supreme Court. “Plaintiffs acknowledge that the FDA repeatedly rejected their proposed labeling change but claim that the FDA lacked four categories of information. This Court held that the materiality of those four categories was a question for the jury at trial,” the memorandum states. “The Supreme Court has now made clear that this Court, not the jury, must resolve the materiality of such information.” A separate memorandum (PDF) submitted on behalf of plaintiffs urged the Court to reject GlaxoSmithKline’s reasoning and proceed with the scheduled jury trials later this year. “(T)here is no dispute in this MDL that the FDA never considered—let alone rejected—a birth defect warning for Zofran with full knowledge of all of the material scientific information that would have supported such a warning,” the plaintiffs wrote. “GSK did not dispute that it had failed to disclose full information concerning at least the three Japanese animal studies and certain adverse event data to the FDA.” Since it is not disputed that the company failed to fully inform the FDA all of available data needed to make a regulatory decision on the label warnings, then there is no need to revisit the summary judgment issue in light of the Supreme Court ruling, plaintiffs argue. If Judge Saylor decides to proceed with the bellwether trials, the outcomes will not be binding on other claims. However, they may greatly influence any Zofran settlement negotiations that would be necessary to avoid the need for hundreds of individual cases to go to trial in courts nationwide. Tags: Birth Defects, GlaxoSmithKline, Pregnancy, Supreme Court, Zofran, Zofran Birth Defects More Zofran Lawsuit Stories Trial Court Dismissal of Zofran Birth Defect Lawsuits Upheld on Appeal Before First Circuit January 10, 2023 Birth Defect Lawsuits Over Zofran Dismissed After Summary Judgment Granted on Federal Preemption June 7, 2021 First Bellwether Trial Over Zofran Birth Defects Set To Begin October 2021 March 5, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (Posted: today) A Florida woman’s Depo-Provera lawsuit indicates she developed hearing loss and tinnitus due to the birth control injection not being adequately tested. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025)Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (04/01/2025) Nurse Assist Lawsuit Alleges Infection Caused by Saline Solution Used To Clean Wounds (Posted: yesterday) A lawsuit filed over recalled Nurse Assist sterile water and saline products indicates the lack of sterility led to infections in leg wounds they were supposed to cleanse. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITMcKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (03/21/2025)SteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023) Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (Posted: 4 days ago) A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis. MORE ABOUT: OZEMPIC LAWSUITOzempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (03/27/2025)Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)
Trial Court Dismissal of Zofran Birth Defect Lawsuits Upheld on Appeal Before First Circuit January 10, 2023
Birth Defect Lawsuits Over Zofran Dismissed After Summary Judgment Granted on Federal Preemption June 7, 2021
Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (Posted: today) A Florida woman’s Depo-Provera lawsuit indicates she developed hearing loss and tinnitus due to the birth control injection not being adequately tested. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025)Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (04/01/2025)
Nurse Assist Lawsuit Alleges Infection Caused by Saline Solution Used To Clean Wounds (Posted: yesterday) A lawsuit filed over recalled Nurse Assist sterile water and saline products indicates the lack of sterility led to infections in leg wounds they were supposed to cleanse. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITMcKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (03/21/2025)SteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)
Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (Posted: 4 days ago) A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis. MORE ABOUT: OZEMPIC LAWSUITOzempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (03/27/2025)Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)